December 11, 2018
Sponsored by
PerkinElmer

Assessing the Impact of Different Aneuploid Findings with Independent NGS Platforms

GenomeWebinar

Genetic Laboratory Director,
Repromeda Biology Park

This webinar describes a study that used two independent next-generation sequencing (NGS) platforms to gain insight into the impact of different types of aneuploidies during preimplantation genetic testing.

Preimplantation genetic testing of aneuploidies (PGT-A) enables the selection of euploid embryos in order to increase implantation rates and reduce miscarriage rates after embryo transfer. NGS platforms provide high resolution and dynamic range for detection of sub-chromosomal segmental aneuploidies and mosaicism, but the impact of these findings remains unclear.

In this webinar, Jakub Horák of Repromeda, a center for reproductive medicine and preimplantation genetic diagnosis in the Czech Republic, will describe a study that compared the reproducibility of different aneuploid findings in order to gain a better understanding of their impact.

The study included 95 embryos that previously analyzed at the blastocyst stage (day 5/6) by trophectoderm biopsy and the VeriSeq™ PGS Kit from Illumina. After blastocyst re-expansion, a second trophectoderm sample of the same size was biopsied for analysis using the PG-Seq™ platform from Perkin Elmer. While detection of whole chromosomal aneuploidy was highly concordant between two samples of the same embryo (97 percent), poor reproducibility (10 percent to 50 percent) was observed for segmentals and mosaics.

These results are consistent with the assumption that the vast majority of whole chromosomal aneuploidies originate in meiosis and affect the whole embryo. In contrast, segmentals and mosaics result from genetic instability in the first mitotic divisions during early embryo development and could possibly result in a healthy livebirth when chromosomally normal cell lines are present in the developing embryo.

Dr. Horák will discuss the impact of these conclusions, including the fact that these findings should be reflected in PGT-A result reporting and patient counselling.

Sponsored by

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nov
29
Sponsored by
Schott

This webinar will discuss how understanding the relative performance characteristics of glass and polymer substrates for in vitro diagnostic applications such as microarrays and microfluidics can help to optimize diagnostic performance.

Dec
03
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.

Dec
04
Sponsored by
Sophia Genetics

This webinar will discuss the use of clinical-grade exome analysis application in complex case investigations.

Dec
11
Sponsored by
PerkinElmer

This webinar describes a study that used two independent next-generation sequencing (NGS) platforms to gain insight into the impact of different types of aneuploidies during preimplantation genetic testing.